Kodak re-enters pharma to manufacture APIs

Good intentions and good troubles

0
51
Kodak
Kodak stock price over the year. Screenshot via Internet 3 August 2020, 1030am India time

One of the big news stories to come out of the US last week was the US$ 765 million loan from the US government’s International Finance Department Corporation (possibly over several years) to Kodak to manufacture pharmaceutical ingredients, also known as active pharmaceutical ingredients (APIs). There was some excitement about…

Choose your subscription to read more

Trial

0 /mo
Not sure which package to choose? Try full access
  • ₹ 0 for 4 weeks*

PSA Plan 1

1000 /year
Access to the website, weekly eMail newsletter
  • ₹1,000.00 for 1 year*

PSA Plan 2

1500 /Year
Access to the website, weekly eMail newsletter and monthly eMag
  • ₹1500 for Year*

PSA Plan 3

2000 /Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
  • ₹2,000.00 for 1 year*

Previous articleCosmo Films continues its green journey
Next articleNutpods launches oat creamers in SIG’s combidome packaging
Naresh Khanna
Editor of Indian Printer and Publisher since 1979 and Packaging South Asia since 2007. Trained as an offset printer and IBM 360 computer programmer. Active in the movement to implement Indian scripts for computer-aided typesetting. Worked as a consultant and trainer to the Indian print and newspaper industry. Visiting faculty of IDC at IIT Powai in the 1990s. Also founder of IPP Services, Training and Research and has worked as its principal industry researcher since 1999. Author of book: Miracle of Indian Democracy.